| Active principles | Rating | Bibliogr. | Expand |
---|
1 | Cytosine | 100 | + | |
2 | Organophosphorus Compounds | 72 | + | |
3 | Organophosphonates | 55 | + | |
4 | DNA | 33 | + | |
5 | Vaccines, DNA | 17 | + | |
6 | Antibodies, Viral | 15 | + | |
7 | DNA, Viral | 15 | + | |
8 | Viral Vaccines | 13 | + | |
9 | Acyclovir | 12 | + | |
10 | Viral Proteins | 11 | + | |
11 | Oseltamivir | 10 | + | |
12 | Hemagglutinin Glycoproteins, Influenza Virus | 10 | + | |
13 | Interferon-alpha | 9 | + | |
14 | Neuraminidase | 9 | + | |
15 | Viral Envelope Proteins | 9 | + | |
16 | RNA, Viral | 9 | + | |
17 | Interferons | 9 | + | |
18 | Recombinant Proteins | 8 | + | |
19 | Influenza Vaccines | 8 | + | |
20 | Ribavirin | 8 | + | |
21 | Vaccines, Synthetic | 7 | + | |
22 | Antibodies, Neutralizing | 6 | + | |
23 | Ribonucleosides | 6 | + | |
24 | Receptors, Virus | 6 | + | |
25 | Hepatitis B Vaccines | 6 | + | |
26 | Zanamivir | 6 | + | |
27 | Poly I-C | 5 | + | |
28 | Immunoglobulin G | 5 | + | |
29 | Vaccines, Inactivated | 5 | + | |
30 | Interferon-gamma | 5 | + | |
31 | Hemagglutinins, Viral | 5 | + | |
32 | Adenine | 5 | + | |
33 | Viral Matrix Proteins | 5 | + | |
34 | Interferon Type I | 5 | + | |
35 | Lamivudine | 5 | + | |
36 | Zidovudine | 5 | + | |
37 | Hepatitis B Antibodies | 5 | + | |
38 | Viral Fusion Proteins | 5 | + | |
39 | Vaccines, Attenuated | 5 | + | |
40 | Hepatitis C Antibodies | 5 | + | |
41 | Rimantadine | 5 | + | |
42 | Polyethylene Glycols | 5 | + | |
43 | DNA Primers | 5 | + | |
44 | DNA-Directed DNA Polymerase | 5 | + | |
45 | Viral Nonstructural Proteins | 4 | + | |
46 | Cytokines | 4 | + | |
47 | DNA, Recombinant | 4 | + | |
48 | Alanine Transaminase | 4 | + | |
49 | Amantadine | 4 | + | |
50 | Arabinofuranosyluracil | 4 | + | |
51 | DNA, Circular | 4 | + | |
52 | DNA, Neoplasm | 4 | + | |
53 | Pyrans | 4 | + | |
54 | Nucleoproteins | 4 | + | |
55 | Respiratory Syncytial Virus Vaccines | 4 | + | |
56 | Sialic Acids | 4 | + | |
57 | Viral Core Proteins | 4 | + | |
58 | Immunoglobulin A | 4 | + | |
59 | Viral Hepatitis Vaccines | 4 | + | |
60 | Immunoglobulins | 4 | + | |
61 | Antibodies, Monoclonal | 4 | + | |
62 | HIV Antibodies | 4 | + | |
63 | Polylysine | 3 | + | |
64 | AIDS Vaccines | 3 | + | |
65 | Cyclopentanes | 3 | + | |
66 | Foscarnet | 3 | + | |
67 | Immunoglobulin M | 3 | + | |
68 | Nucleosides | 3 | + | |
69 | Phosphonoacetic Acid | 3 | + | |
70 | West Nile Virus Vaccines | 3 | + | |
71 | Guanine | 3 | + | |
72 | Acetamides | 3 | + | |
73 | Hepatitis Antibodies | 3 | + | |
74 | Viral Structural Proteins | 3 | + | |
75 | Ganciclovir | 3 | + | |
76 | Bacterial Proteins | 3 | + | |
77 | Thymidine | 3 | + | |
78 | Smallpox Vaccine | 3 | + | |
79 | Vaccines, Subunit | 3 | + | |
80 | Recombinant Fusion Proteins | 3 | + | |
81 | DNA, Single-Stranded | 3 | + | |
82 | Nucleocapsid Proteins | 3 | + | |
83 | Immune Sera | 3 | + | |
84 | Interleukins | 3 | + | |
85 | Vidarabine | 3 | + | |
86 | Bacterial Vaccines | 3 | + | |
87 | DNA-Directed RNA Polymerases | 3 | + | |
88 | Gene Products, gag | 3 | + | |
89 | DNA, Complementary | 2 | + | |
90 | Zalcitabine | 2 | + | |
91 | Antibodies, Bacterial | 2 | + | |
92 | Poly U | 2 | + | |
93 | Gene Products, env | 2 | + | |
94 | Aerosols | 2 | + | |
95 | DNA, Mitochondrial | 2 | + | |
96 | Cephalosporins | 2 | + | |
97 | Guanidines | 2 | + | |
98 | Trimethoprim-Sulfamethoxazole Combination | 2 | + | |
99 | Membrane Glycoproteins | 2 | + | |
100 | Idoxuridine | 2 | + | |
101 | 2-Aminopurine | 2 | + | |
102 | RNA, Double-Stranded | 2 | + | |
103 | Cord Factors | 2 | + | |
104 | DNA Probes | 2 | + | |
105 | Penicillins | 2 | + | |
106 | Interleukin-12 | 2 | + | |
107 | RNA-Directed DNA Polymerase | 2 | + | |
108 | HIV Core Protein p24 | 2 | + | |
109 | Receptors, CCR5 | 2 | + | |
110 | Rabies Vaccines | 2 | + | |
111 | Immunoglobulins, Intravenous | 2 | + | |
112 | HN Protein | 2 | + | |
113 | Oligodeoxyribonucleotides | 2 | + | |
114 | Carboxymethylcellulose Sodium | 2 | + | |
115 | Retroviridae Proteins, Oncogenic | 2 | + | |
116 | Ciprofloxacin | 2 | + | |
117 | Glycoproteins | 2 | + | |
118 | DNA, Fungal | 2 | + | |
119 | Gentamicins | 2 | + | |
120 | Japanese Encephalitis Vaccines | 2 | + | |
121 | Antibodies | 2 | + | |
122 | HIV Envelope Protein gp120 | 2 | + | |
123 | Vidarabine Phosphate | 2 | + | |
124 | Chemokines | 2 | + | |
125 | Pseudorabies Vaccines | 2 | + | |
126 | Receptors, Interferon | 2 | + | |
127 | Praziquantel | 2 | + | |
128 | Antibodies, Protozoan | 2 | + | |
129 | Poly C | 2 | + | |
130 | Didanosine | 2 | + | |
131 | Dengue Vaccines | 2 | + | |
132 | Oligonucleotide Probes | 2 | + | |
133 | Tumor Necrosis Factor-alpha | 2 | + | |
134 | Trimethoprim | 2 | + | |
135 | RNA-Binding Proteins | 2 | + | |
136 | Antigens, CD81 | 2 | + | |
137 | DNA, Protozoan | 2 | + | |
138 | Thymosin | 2 | + | |
139 | Metronidazole | 2 | + | |
140 | Amphotericin B | 2 | + | |
141 | Thymidine Kinase | 2 | + | |
142 | Acetylmuramyl-Alanyl-Isoglutamine | 2 | + | |
143 | Plantibodies | 2 | + | |
144 | Uridine Monophosphate | 2 | + | |
145 | Neutral Red | 2 | + | |
146 | Interleukin-2 | 2 | + | |
147 | Immunoglobulin A, Secretory | 2 | + | |
148 | RNA | 2 | + | |
149 | Valine | 2 | + | |
150 | Poly I | 2 | + | |
151 | RNA Replicase | 2 | + | |
152 | RNA, Transfer | 2 | + | |
153 | RNA, Messenger | 2 | + | |
154 | Cholera Toxin | 2 | + | |
155 | Oligopeptides | 2 | + | |
156 | Polyribonucleotides | 2 | + | |
157 | ISCOMs | 2 | + | |
158 | Interleukin-4 | 2 | + | |
159 | Cryoglobulins | 2 | + | |
160 | Receptors, KIR2DL3 | 2 | + | |
161 | Arabinonucleotides | 1 | + | |
162 | Sulfamethoxazole | 1 | + | |
163 | Ampicillin | 1 | + | |
164 | Interleukin-10 | 1 | + | |
165 | Capsid Proteins | 1 | + | |
166 | Protozoan Vaccines | 1 | + | |
167 | Cefazolin | 1 | + | |
168 | Inosine Pranobex | 1 | + | |
169 | Fluoroquinolones | 1 | + | |
170 | Herpesvirus Vaccines | 1 | + | |
171 | Plant Extracts | 1 | + | |
172 | Chemokine CCL5 | 1 | + | |
173 | Protein Precursors | 1 | + | |
174 | Fluconazole | 1 | + | |
175 | Transaminases | 1 | + | |
176 | 5' Untranslated Regions | 1 | + | |
177 | Clindamycin | 1 | + | |
178 | Amoxicillin | 1 | + | |
179 | Azithromycin | 1 | + | |
180 | Hepatitis A Vaccines | 1 | + | |
181 | Propiolactone | 1 | + | |
182 | beta-Lactamases | 1 | + | |
183 | Ofloxacin | 1 | + | |
184 | Toll-Like Receptors | 1 | + | |
185 | Immunoglobulin Isotypes | 1 | + | |
186 | Vaccines, Virosome | 1 | + | |
187 | DNA, Bacterial | 1 | + | |
188 | Gene Products, pol | 1 | + | |
189 | RNA, Small Interfering | 1 | + | |
190 | Toll-Like Receptor 3 | 1 | + | |
191 | Green Fluorescent Proteins | 1 | + | |
192 | Rifampin | 1 | + | |
193 | Morpholinos | 1 | + | |
194 | DNA, Helminth | 1 | + | |
195 | Ubiquitins | 1 | + | |
196 | Trifluridine | 1 | + | |
197 | Peptide Fragments | 1 | + | |
198 | Aspartate Aminotransferases | 1 | + | |
199 | Ceftriaxone | 1 | + | |
200 | Dianhydrogalactitol | 1 | + | |
201 | Antigens, CD56 | 1 | + | |
202 | Peptides | 1 | + | |
203 | Cefotaxime | 1 | + | |
204 | Doxycycline | 1 | + | |
205 | 3' Untranslated Regions | 1 | + | |
206 | DNA (Cytosine-5-)-Methyltransferase | 1 | + | |
207 | Interleukin-15 | 1 | + | |
208 | Carbocysteine | 1 | + | |
209 | Mumps Vaccine | 1 | + | |
210 | Antibodies, Monoclonal, Humanized | 1 | + | |
211 | Interferon-beta | 1 | + | |
212 | Phenazines | 1 | + | |
213 | Tobramycin | 1 | + | |
214 | Membrane Proteins | 1 | + | |
215 | Marek Disease Vaccines | 1 | + | |
216 | Norfloxacin | 1 | + | |
217 | Oxazolidinones | 1 | + | |
218 | Inosine Monophosphate | 1 | + | |
219 | Bromodeoxyuridine | 1 | + | |
220 | DNA Glycosylases | 1 | + | |
221 | env Gene Products, Human Immunodeficiency Virus | 1 | + | |
222 | Interleukin-18 | 1 | + | |
223 | NK Cell Lectin-Like Receptor Subfamily C | 1 | + | |
224 | Myxovirus Resistance Proteins | 1 | + | |
225 | Clarithromycin | 1 | + | |
226 | Herpes Simplex Virus Vaccines | 1 | + | |
227 | Receptors, CCR7 | 1 | + | |
228 | DEAD-box RNA Helicases | 1 | + | |
229 | tat Gene Products, Human Immunodeficiency Virus | 1 | + | |
230 | Macrolides | 1 | + | |
231 | Staphylococcal Protein A | 1 | + | |
232 | Adaptor Proteins, Vesicular Transport | 1 | + | |
233 | Histocompatibility Antigens Class I | 1 | + | |
234 | Cefoxitin | 1 | + | |
235 | Protozoan Proteins | 1 | + | |
236 | Lactams | 1 | + | |
237 | Glycopeptides | 1 | + | |
238 | eIF-2 Kinase | 1 | + | |
239 | Dideoxynucleotides | 1 | + | |
240 | Imipenem | 1 | + | |
241 | Pyrimidine Nucleosides | 1 | + | |
242 | Chemokine CXCL10 | 1 | + | |
243 | Vaccines | 1 | + | |
244 | Aminoquinolines | 1 | + | |
245 | Polysaccharides | 1 | + | |
246 | Receptors, Chemokine | 1 | + | |
247 | beta-Lactams | 1 | + | |
248 | Oligonucleotides, Antisense | 1 | + | |
249 | Bacterial Outer Membrane Proteins | 1 | + | |
250 | Sulbactam | 1 | + | |
251 | Escherichia coli Proteins | 1 | + | |
252 | beta-Galactosidase | 1 | + | |
253 | Luciferases | 1 | + | |
254 | Minocycline | 1 | + | |
255 | Erythromycin | 1 | + | |
256 | Cefamandole | 1 | + | |
257 | Sesquiterpenes, Germacrane | 1 | + | |
258 | gamma-Globulins | 1 | + | |
259 | HIV Reverse Transcriptase | 1 | + | |
260 | Cefuroxime | 1 | + | |
261 | Ebola Vaccines | 1 | + | |
262 | 2',5'-Oligoadenylate Synthetase | 1 | + | |
263 | Inosine | 1 | + | |
264 | Carbapenems | 1 | + | |
265 | Adamantane | 1 | + | |
266 | DNA, Ribosomal | 1 | + | |
267 | Pentamidine | 1 | + | |
268 | Piperacillin | 1 | + | |
269 | Interferon Regulatory Factor-3 | 1 | + | |
270 | RNA, Catalytic | 1 | + | |
271 | Colistin | 1 | + | |
272 | Isoniazid | 1 | + | |
273 | Interleukin-6 | 1 | + | |
274 | Itraconazole | 1 | + | |
275 | Aminoglycosides | 1 | + | |
276 | Carrier Proteins | 1 | + | |
277 | Penicillanic Acid | 1 | + | |
278 | Teicoplanin | 1 | + | |
279 | Papillomavirus Vaccines | 1 | + | |
280 | Measles Vaccine | 1 | + | |
281 | HIV Envelope Protein gp160 | 1 | + | |
282 | Luminescent Proteins | 1 | + | |
283 | Ceftazidime | 1 | + | |
284 | Receptors, CXCR4 | 1 | + | |
285 | nef Gene Products, Human Immunodeficiency Virus | 1 | + | |
286 | Tetracycline | 1 | + | |
287 | Toll-Like Receptor 7 | 1 | + | |
288 | Thienamycins | 1 | + | |
289 | DNA, Plant | 1 | + | |
290 | DNA, Superhelical | 1 | + | |
291 | Autoantibodies | 1 | + | |
292 | Aztreonam | 1 | + | |
293 | Antigens, CD4 | 1 | + | |
294 | Pyrimidinones | 1 | + | |
295 | Cilastatin | 1 | + | |
296 | DNA Ligases | 1 | + | |
297 | Gene Products, nef | 1 | + | |
298 | Deoxycytosine Nucleotides | 1 | + | |
299 | Stavudine | 1 | + | |
300 | Povidone-Iodine | 1 | + | |
301 | Triazoles | 1 | + | |
302 | Codon | 1 | + | |
303 | Nitrous Acid | 1 | + | |
304 | Lipopolysaccharides | 1 | + | |
305 | Granulocyte-Macrophage Colony-Stimulating Factor | 1 | + | |
306 | Antimicrobial Cationic Peptides | 1 | + | |
307 | Urease | 1 | + | |
308 | Proteins | 1 | + | |
309 | Drugs, Chinese Herbal | 1 | + | |
310 | Receptors, CCR2 | 1 | + | |
311 | Penicillin G | 1 | + | |
312 | GTP-Binding Proteins | 1 | + | |
313 | Daptomycin | 1 | + | |
314 | Lysosomal-Associated Membrane Protein 1 | 1 | + | |
315 | Programmed Cell Death 1 Receptor | 1 | + | |
316 | Uridine | 1 | + | |
317 | Quinolones | 1 | + | |
318 | HIV Envelope Protein gp41 | 1 | + | |
319 | DNA Polymerase II | 1 | + | |
320 | Biopolymers | 1 | + | |
321 | Methicillin | 1 | + | |
322 | Histocompatibility Antigens Class II | 1 | + | |
323 | Keratin-5 | 1 | + | |
324 | Diminazene | 1 | + | |
325 | Echinocandins | 1 | + | |
326 | Oncogene Proteins, Viral | 1 | + | |
327 | Interferon-Stimulated Gene Factor 3 | 1 | + | |
328 | Chickenpox Vaccine | 1 | + | |
329 | Deoxyribonucleases | 1 | + | |
330 | Lactoferrin | 1 | + | |
331 | Alcian Blue | 1 | + | |
332 | Cyclophosphamide | 1 | + | |
333 | Vaccines, Marker | 1 | + | |
334 | DNA Helicases | 1 | + | |
335 | Helminth Proteins | 1 | + | |
336 | STAT1 Transcription Factor | 1 | + | |
337 | Nystatin | 1 | + | |
338 | DNA, Catalytic | 1 | + | |
339 | Vaccines, Virus-Like Particle | 1 | + | |
340 | Vaccines, Combined | 1 | + | |
341 | Lipopeptides | 1 | + | |
342 | Interleukin-1 | 1 | + | |
343 | Cephalexin | 1 | + | |
344 | Aminacrine | 1 | + | |
345 | Levofloxacin | 1 | + | |
346 | Thiosemicarbazones | 1 | + | |
347 | Ritonavir | 1 | + | |
348 | Cephamycins | 1 | + | |
349 | Receptors, Polymeric Immunoglobulin | 1 | + | |
350 | Nitrofurantoin | 1 | + | |
351 | Oxazines | 1 | + | |
352 | Quercetin | 1 | + | |
353 | Oxidoreductases Acting on CH-CH Group Donors | 1 | + | |
354 | Natural Cytotoxicity Triggering Receptor 1 | 1 | + | |
355 | Clavulanic Acids | 1 | + | |
356 | Prednisolone | 1 | + | |
357 | Galactosylceramides | 1 | + | |
358 | Virginiamycin | 1 | + | |
359 | Silver | 1 | + | |
360 | Bromine | 1 | + | |
361 | Glucocorticoids | 1 | + | |
362 | Amikacin | 1 | + | |
363 | Nitroimidazoles | 1 | + | |
364 | Receptors, KIR | 1 | + | |
365 | Fungal Vaccines | 1 | + | |
366 | Prednisone | 1 | + | |
367 | Ketoconazole | 1 | + | |
368 | Fosfomycin | 1 | + | |
369 | Cephalothin | 1 | + | |
370 | Amoxicillin-Potassium Clavulanate Combination | 1 | + | |
371 | Amides | 1 | + | |
372 | Levamisole | 1 | + | |
373 | Dimethyl Sulfoxide | 1 | + | |
374 | Oxacillin | 1 | + | |
375 | Moxalactam | 1 | + | |
376 | Mupirocin | 1 | + | |
377 | NK Cell Lectin-Like Receptor Subfamily K | 1 | + | |
378 | Staphylococcal Vaccines | 1 | + | |
379 | Interleukin-7 Receptor alpha Subunit | 1 | + | |
380 | MicroRNAs | 1 | + | |
381 | Polymyxins | 1 | + | |
382 | Receptors, Antigen, T-Cell, gamma-delta | 1 | + | |